BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07508995-completion@plaintrial.com
DTSTAMP:20260928T055401Z
DTSTART;VALUE=DATE:20330701
SUMMARY:A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In
  Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-
 Naive Chronic Lymphocytic Leukemia (CLL) — estimated completion date
DESCRIPTION:Not yet recruiting. Saved on your PlainTrial shortlist. Full tr
 ial record: https://plaintrial.com/trial/NCT07508995
URL:https://plaintrial.com/trial/NCT07508995
END:VEVENT
END:VCALENDAR